Related Experiment Video
Updated: May 27, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant
Ana Maria Rivera1, Helen W Boucher
1Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA 02111, USA.
Abstract:
Gram-positive bacteria cause a broad spectrum of disease in immunocompetent and immunocompromised hosts. Despite increasing knowledge about resistance transmission patterns and new antibiotics, these organisms continue to cause significant morbidity and mortality, especially in the health care setting. Methicillin-resistant Staphylococcus aureus poses major problems worldwide as a cause of nosocomial infection and has emerged as a cause of community-acquired infections. This change in epidemiology affects choices of empirical antibiotics for skin and skin-structure infections and community-acquired pneumonia in many settings. Throughout the world, the treatment of community-acquired pneumonia and other respiratory tract infections caused by penicillin-resistant Streptococcus pneumoniae has been complicated by resistance to β-lactam and macrolide antibacterial drugs. Vancomycin-resistant enterococci are a major cause of infection in the hospital setting and remain resistant to treatment with most standard antibiotics. Treatment of diseases caused by resistant gram-positive bacteria requires appropriate use of available antibiotics and stewardship to prolong their effectiveness. In addition, appropriate and aggressive infection control efforts are vital to help prevent the spread of resistant pathogens.
Insights
Resistant gram-positive bacteria, including MRSA and VRE, cause severe infections, particularly in healthcare settings. Effective treatment requires antibiotic stewardship and stringent infection control to combat rising antimicrobial resistance.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Gram-positive bacteria are significant causes of disease in diverse patient populations.
- Antimicrobial resistance in these pathogens, especially in healthcare settings, leads to substantial morbidity and mortality.
- Emerging resistance patterns, such as Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci (VRE), complicate treatment strategies.
Purpose of the Study:
- To review the challenges posed by drug-resistant gram-positive bacterial infections.
- To highlight the impact of resistance on treatment choices for common infections like pneumonia and skin infections.
- To emphasize the importance of antimicrobial stewardship and infection control.
Main Methods:
- Literature review of current research on gram-positive bacterial resistance.
- Analysis of epidemiological trends in nosocomial and community-acquired infections.
- Synthesis of treatment guidelines and recommendations for resistant pathogens.
Main Results:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a global concern for both hospital-acquired and community-acquired infections.
- Penicillin-resistant Streptococcus pneumoniae complicates the treatment of respiratory tract infections due to resistance to beta-lactam and macrolide drugs.
- Vancomycin-resistant enterococci (VRE) are prevalent in hospitals and resistant to most standard antibiotics.
Conclusions:
- Effective management of diseases caused by resistant gram-positive bacteria necessitates judicious antibiotic use and stewardship programs.
- Aggressive infection control measures are crucial for preventing the transmission of resistant strains.
- A multifaceted approach combining antimicrobial stewardship and infection control is vital to preserve antibiotic effectiveness.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
